Eligibility
cSCC, cSCC lesions
MAY
Between May 2015 and March 2018, those adult kidney transplant recipients with cSCC lesions considered to be aggressive or with bad evolution despite primary treatment (consisted of surgical clearance) and close follow-up by a dedicated team of dermatologists were invited to participate. After signing the consent form, patients were considered eligible if they had high-risk cSCC as defined below, had more than 12 months after transplantation and, in the past six months, had no treated acute allograft rejection episodes, presented stable kidney function (defined by estimated glomerular filtration rate ≥ 40 mL/min/1.73m